Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Patent CN108026017B reveals a novel tetraalkylammonium-catalyzed method for producing acid halide solutions, enabling cost reduction in electronic chemical manufacturing and high-purity intermediates.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Patent CN113735867B introduces mild room temperature synthesis of chiral indolo-oxa compounds with high yield and enantioselectivity offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing
Novel ruthenium-catalyzed asymmetric cyclopropanation achieves high enantioselectivity trans-D-chrysanthemic acid with simplified process flow ensuring reliable supply chain efficiency for agrochemical manufacturers.
Patent CN119798149A introduces a three-step synthesis route eliminating hazardous reagents with enhanced purity control and scalable manufacturing for pharmaceutical intermediates.
Novel chiral indolinopyrrole synthesis via phosphoric acid catalysis achieves high enantioselectivity and scalability, enabling cost-effective API intermediate production for oncology therapeutics.
Breakthrough chiral phosphoric acid catalyst with spiro-bis-dihydrobenzothiole skeleton enables high-enantioselectivity asymmetric synthesis for pharmaceutical intermediates, offering reliable supply chain and cost reduction.
Novel chiral phosphoric acid-catalyzed synthesis achieves high enantioselectivity and yield for N-N axis pyrrole derivatives, enabling cost-effective pharmaceutical production with enhanced supply chain reliability.
Patent CN114478245A enables high-purity chiral intermediates with streamlined manufacturing and enhanced supply chain resilience for pharmaceutical applications.
Patent CN113880781B enables high-purity triazole synthesis using biomass glucose with mild conditions and scalable manufacturing advantages.
Patent CN119060057B introduces a mild chiral phosphoric acid-catalyzed synthesis of indolocyclopentanes with high yield and selectivity, enabling scalable production and significant cost savings for pharmaceutical intermediates.
Novel one-step AlCl3-catalyzed carboxylation process eliminates hazardous reagents while delivering high-purity API intermediates with enhanced supply chain reliability and sustainable cost reduction.
Breakthrough chiral indoxazinone synthesis with high enantioselectivity enables cost-effective manufacturing and reliable supply chain for oncology drug development.
Innovative chiral phosphoric acid catalyzed process delivers high enantioselectivity and yield for pharmaceutical intermediates ensuring scalable cost-effective production with stringent purity standards
Patent CN113880781B enables mild glucose-driven synthesis of trifluoromethyl triazoles with scalable production and enhanced supply chain efficiency for pharmaceutical intermediates.
Patent CN115925722B enables industrial-scale synthesis of key tazobactam intermediate through optimized copper halide halogenation, eliminating pollution and enhancing supply chain reliability for pharmaceutical manufacturers.
Patent CN118878452B enables high-yield synthesis under mild conditions with significant cost savings for reliable pharmaceutical intermediate supply chains.